High-throughput screening for kinase inhibitors

Area of Science:

• Biochemistry
• Pharmacology
• Drug Discovery

Background:

• Protein kinases represent the second most significant class of drug targets after G protein-coupled receptors (GPCRs).
• Despite numerous kinase inhibitors in clinical development, only a few have reached the market, highlighting the need for continued research.
• The identification of 518 human protein kinases underscores their potential as therapeutic targets.

Purpose of the Study:

• To provide an overview of state-of-the-art assay development for protein kinase inhibitors.
• To guide readers through efficient high-throughput screening strategies for identifying novel kinase inhibitors.
• To focus on the early stages of drug discovery programs for generating new lead compounds.

Main Methods:

• Review of current methodologies in assay development for protein kinase inhibition.
• Discussion of high-throughput screening (HTS) techniques applied to large chemical libraries.
• Analysis of strategies for identifying and optimizing lead compounds against protein kinase targets.

Main Results:

• Protein kinases are increasingly recognized as druggable targets.
• Efficient assay development and HTS are critical for discovering novel kinase inhibitors.
• The field is poised for significant growth in kinase inhibitor drug discovery.

Conclusions:

• Protein kinase inhibitors are a rapidly expanding area in drug discovery.
• Advanced assay development and HTS are essential for identifying new therapeutic agents.
• Future research will likely focus on expanding the repertoire of kinase inhibitors for various diseases.